Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.11
Delayed Data
As of Apr 24
 0.00 / 0.00%
Today’s Change
0.82
Today|||52-Week Range
1.76
-3.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash15.1M10.7M5.1M27.1M
 
 
 
 
 
Short Term Investment Cash7.1M-4.5M-5.5M22.0M
 
 
 
 
 
Cash & Short Term Investments15.1M10.7M5.1M27.1M
 
 
 
 
 
 
ReceivablesReceivables0.0023.7K0.000.00
 
 
 
InventoriesInventories0.00--0.000.00--
 
Current AssetsOther Current Assets279.8K328.2K438.2K355.9K
 
 
 
 
 
Current Assets15.4M11.0M5.6M27.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross255.1K486.9K512.3K491.6K
 
 
 
 
 
Depreciation-177.0K-225.2K-293.5K-262.0K
 
 
 
 
 
Other Assets18.0K26.0K38.2K34.5K
 
 
 
 
 
Total Assets15.5M11.3M5.8M27.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable158.3K491.6K884.1K1.1M
 
 
 
 
 
Accrued Expenses400.0K417.8K165.4K251.0K
 
 
 
 
 
Other Current Liabilities406.9K427.4K169.5K251.0K
 
 
 
 
 
Other Liabilities565.2K919.0K1.1M1.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.001.4M1.5M1.5M
 
 
 
 
Other Liabilities0.009.4M9.4M4.1M
 
 
 
 
Total Liabilities565.2K11.7M11.9M6.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity14.9M-422.2K-6.1M20.8M
 
 
 
 
 
Total Shareholder Equity14.9M-422.2K-6.1M20.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding27.0M32.4M32.4M60.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.